Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 3, 2013, Pages 177-183

  Igawa, Yasuhiko ^a   Michel, Martin C ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bladder; Mirabegron; Ritobegron; Solabegron

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; KUC 7322; MIRABEGRON; RITOBEGRON; SOLABEGRON; UNCLASSIFIED DRUG;

BLADDER DYSFUNCTION; BLOOD PRESSURE; CLINICAL EFFECTIVENESS; DETRUSOR MUSCLE; DRUG EFFICACY; DRUG POTENCY; DRUG USE; HUMAN; IN VIVO STUDY; NONHUMAN; OVERACTIVE BLADDER; REVIEW; URINARY FREQUENCY;

ADRENERGIC BETA-3 RECEPTOR AGONISTS; ANIMALS; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; RECEPTORS, ADRENERGIC, BETA-3; SYNDROME; URINARY BLADDER, OVERACTIVE;

EID: 84877917378     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0824-1     Document Type: Review

References (39)

1. 3-adrenoceptor agonist, on the primary bladder afferent activity and bladder microcontractions in rats in comparison with those of oxybutynin. Eur Urol 62:1166-1173
2. 3-adrenoceptor agonists on pharmacology, physiology and obesity drug discovery. Naunyn-Schmiedeberg's Arch Pharmacol 378:225-240
3. 3-adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder. BJU Int 98:1310-1314
4. Brown L, Deighton NM, Bals S, Söhlmann W, Zerkowski H-R, Michel MC, Brodde O-E (1992) Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222-232
5. 3-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 385:875-882
6. Comiter C (2012) Local renin-angiotensin systems in the genitourinary tract. Naunyn-Schmiedeberg's Arch Pharmacol 385:13-26
7. Evans BA, Sato M, Sarwar M, Hutchinson DS, Summers RJ (2010) Ligand-directed signalling at β-adrenoceptors. Br J Pharmacol 159:1022-1038
8. 3- adrenoceptor agonist. Eur J Pharmacol 654:86-91
9. 3-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. BJU Int 110:E132-E142
10. 3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol 294:G1114-G1119
11. 3- adrenoceptor agonist, on bladder function during storage phase in rats. Naunyn-Schmiedeberg's Arch Phamacol. doi: 10.1007/s00210-012-0814-3
12. 3-adrenoceptor agonist mirabegron in rats. Naunyn-Schmiedeberg's Arch Pharmacol. doi: 10.1007/s00210-012-0821-4
13. 3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther 323:202-209
14. 3- adrenoceptor agonist KUC-7322. Naunyn-Schmiedeberg's Arch Pharmacol 385:759-767
15. Kullmann FA, Downs TR, Artim DE, Limberg BJ, Shah M, Contract D, De Groat WC, Rosenbaum JS (2011) Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol Urodyn 30:144-150
16. Kyung YS, Park H, Lee G (2012) Intravesical epinephrine preserves uroplakin II expression in urinary bladder from cyclophosphamide-induced rat cystitis. Naunyn-Schmiedeberg's Arch Pharmacol 385:769-776
17. 3-adrenoceptor agonist: on the in vitro and in vivo studies. Naunyn-Schmiedeberg's Arch Pharmacol 385:845-852
18. 3-adrenoceptor agonist, on bladder function in cynomolgus monkey. J Pharmacol Exp Ther 342:163-168
19. 3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 29:1320-1325
20. Michel MC, Sand C (2009) Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder. World J Urol 27:711-715
21. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147:S88-S119
22. Michel MC, Ochodnicky P, Homma Y, Igawa Y (2011) β-Adrenoceptor agonist effects in experimental models of bladder dysfunction. Pharmacol Ther 131:40-49
23. 3-adrenoceptors in regulation of retinal vascular tone in rats. Naunyn-Schmiedeberg's Arch Pharmacol 384:603-608
24. Niclauß N, Michel-Reher MB, Alewijnse AE, Michel MC (2006) Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 374:79-85
25. Ochodnicky P, Humphreys S, Eccles R, Poljakovic M, Wiklund P, Michel MC (2012) Expression profiling of G-protein-coupled receptors in human urothelium and related cell lines. BJU Int 110:e293-e300
26. 3-adrenoceptor mediated relaxation in human detrusor muscle. Neurourol Urodyn 28:870-871
27. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson K-E (2009) A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol 56:810-820
28. 3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111:652-673
29. Salameh A, Dhein S (2011) Adrenergic control of cardiac gap junction function and expression. Naunyn-Schmiedeberg's Arch Pharmacol 383:331-346
30. 3- adrenoceptor (AR) agonist, increased functional bladder capacity and decreased micturition frequency in conscious water-loaded cynomolgus monkeys. Eur Urol Suppl 9:111
31. 3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity. Eur J Pharmacol doi: 10.1016/j.ejphar.2012.11.060
32. 3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321:642-647
33. 3- adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol 35:76-83
34. 3 adrenergic receptor agonists. J Med Chem 49:2758-2771
35. Vrydag W, Michel MC (2009) Agonist-dependent desensitization of the β-adrenoceptor-mediated rat urinary bladder relaxation. pA2 online 6: www.pA2online.org/abstracts/Vol6Issue4abst041.pdf
36. 3-adrenoceptors? Br J Pharmacol 156:127-134
37. Witte LPW, de Haas N, Mammen M, Stangeland EL, Steinfeld T, Aiyar J, Michel MC (2011) Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation. Naunyn-Schmiedeberg's Arch Pharmacol 384:555-563
38. Yamazaki Y, Tatemichi S, Maruyama I, Takeda H, Kaidoh K, Kojima M, Akahane S, Shibata N, Akahane M (2002) Characterization of KUC-7483 and its active metabolite, KUC-7322, a selective beta3-adrenoceptor agonist, on bladder function in rats. https://www.icsofficeorg/publications/2002/pdf/095.pdf
39. Yamazaki T, Muraki Y, Anraku T (2011) In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats. Naunyn-Schmiedeberg's Arch Pharmacol 384:319-329